LifeMD Inc
NASDAQ:LFMD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
L
|
LifeMD Inc
NASDAQ:LFMD
|
US |
|
CF Bankshares Inc
NASDAQ:CFBK
|
US |
|
A
|
Anheuser-Busch Inbev SA
SWB:ITKA
|
BE |
LifeMD Inc
LifeMD is a telehealth company that connects patients with doctors and medical care online. It offers virtual visits, online treatment plans, and prescription fulfillment for common health needs such as weight management, men’s health, and primary care. Patients use its digital platform to talk with clinicians, get diagnosed, and receive follow-up care without going to a physical clinic. The company makes money mainly by charging patients for medical visits, memberships, and ongoing treatment programs, and by earning fees tied to prescriptions and related care services. It also works with healthcare providers and pharmacies to deliver the care experience end to end. That means LifeMD sits between the patient, the clinician, and the medication supply chain. What makes its business model different is that it is built around recurring digital care rather than one-time appointments. LifeMD is not just selling software; it is packaging access to doctors, treatment plans, and prescription support into a consumer-friendly online service. That gives it a role as a direct-to-patient healthcare provider with a strong focus on convenience and repeat use.
LifeMD is a telehealth company that connects patients with doctors and medical care online. It offers virtual visits, online treatment plans, and prescription fulfillment for common health needs such as weight management, men’s health, and primary care. Patients use its digital platform to talk with clinicians, get diagnosed, and receive follow-up care without going to a physical clinic.
The company makes money mainly by charging patients for medical visits, memberships, and ongoing treatment programs, and by earning fees tied to prescriptions and related care services. It also works with healthcare providers and pharmacies to deliver the care experience end to end. That means LifeMD sits between the patient, the clinician, and the medication supply chain.
What makes its business model different is that it is built around recurring digital care rather than one-time appointments. LifeMD is not just selling software; it is packaging access to doctors, treatment plans, and prescription support into a consumer-friendly online service. That gives it a role as a direct-to-patient healthcare provider with a strong focus on convenience and repeat use.
Revenue beat: LifeMD reported first-quarter revenue of $50.2 million, ahead of guidance, even though revenue was essentially flat year over year because the mix shifted away from compounded GLP-1s toward branded therapies.
Subscriber growth: The company added more than 42,000 net telehealth subscribers, its largest quarterly net addition ever, ending the quarter with over 365,000 subscribers.
Margins improved: Gross margin expanded to 88%, helped by lower shipping and fulfillment costs and the scaling of the in-house pharmacy.
Investment quarter: Selling and marketing rose sharply as the company front-loaded patient acquisition spending; management said Q1 was the peak for the year and expects marketing to step down in Q2 and stay more normal in the back half.
2026 outlook reaffirmed: LifeMD kept full-year guidance at $220 million to $230 million of revenue and $12 million to $17 million of adjusted EBITDA, while still targeting an annualized run rate above $250 million and adjusted EBITDA above $25 million by Q4.
Strategic shifts: Management emphasized growth in branded GLP-1 partnerships, insurance-supported programs, women’s health, pharmacy expansion, and AI-enabled operating leverage as the key drivers for the second half of 2026.
